Company: GVH
Filing Date: 2025-06-10
Form Type: F-1/A
Source: 0001213900-25-052766
Chunk: 15

Company: Globavend Holdings Ltd
Filing Date: 2025-06-10
Form: F-1/A
Chunk 15
---
sidiaries are not required to obtain any permissions or approvals from Hong Kong authorities before listing in the
U.S. and issuing our Ordinary Shares to foreign investors. No such permissions or approvals have been applied for by the Company
and/or its subsidiaries or denied by any relevant authorities. As of the date of this prospectus, neither of our HK Subsidiaries requires
any requisite permissions or approvals from the Hong Kong authorities to operate its respective businesses. Each of our HK Subsidiaries
has received all requisite permissions or approvals from the Hong Kong authorities to operate its respective businesses in Hong Kong,
including but not limited to its respective business registration certificates. However, we have been advised by our Hong Kong counsel
that uncertainties still exist, due to the possibility that laws, regulations, or policies in Hong Kong could change rapidly in the
future.

Based on Management’s
internal assessment that the Company and its subsidiaries currently have no material operations in the PRC, Management understands that
as of the date of this prospectus, the Company is not required to obtain any permissions or approvals from PRC authorities before listing
in the U.S. and issuing our Ordinary Shares to foreign investors, including the CAC or the CSRC because (i) the CSRC currently
has not issued any definitive rule or interpretation concerning whether offerings like ours under this prospectus are subject to this
regulation; and (ii) the Company operates in Hong Kong and is not included in the categories of industries and companies whose
foreign securities offerings are subject to review by the CSRC or the CAC. We also understand that neither of our HK Subsidiaries
is required to obtain any permissions or approvals from any Chinese authorities to operate its respective businesses as of the date of
this prospectus. No permissions or approvals have been applied for by the Company or denied by any relevant authorities.

In addition, our
Ordinary Shares may be prohibited from trading on a national exchange or over-the-counter market under the Holding Foreign Companies
Accountable Act (the “HFCA Act”) if the Public Company Accounting Oversight Board (United States) (the
“PCAOB”) is unable to inspect our auditors for two consecutive years. Pursuant to the HFCA Act, the PCAOB issued a
Determination Report on December 16, 2021 which found that the PCAOB is unable to inspect or investigate completely registered
public accounting firms headquartered in: (i) mainland China and (ii) Hong Kong; and such
report identified the